Drug Shortage Report for SUFENTANIL CITRATE INJECTION USP

Last updated on 2025-03-12 History
Report ID 234813
Drug Identification Number 02442213
Brand name SUFENTANIL CITRATE INJECTION USP
Common or Proper name SUFENTANIL CITRATE INJECTION USP
Company Name STERIMAX INC
Market Status MARKETED
Active Ingredient(s) SUFENTANIL
Strength(s) 50MCG
Dosage form(s) SOLUTION
Route of administration EPIDURAL INTRAVENOUS EPIDURAL INTRAVENOUS
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 10 X 1 mL Ampoules
ATC code N01AH
ATC description ANESTHETICS, GENERAL
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2024-08-16
Actual start date
Estimated end date 2025-03-14
Actual end date 2025-03-11
Shortage status Resolved
Updated date 2025-03-12
Company comments Coverage in place for contracted customers. Alternatively, Sufentanil Citrate Inj. 5 mL remains available.
Health Canada comments
Tier 3 Status No
Contact Address 2770 PORTLAND DRIVE
OAKVILLE, ONTARIO
CANADA L6H 6R4
Company contact information 1-800-881-3550

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v19 2025-03-12 French Compare
v18 2025-03-12 English Compare
v17 2025-03-06 French Compare
v16 2025-03-06 English Compare
v15 2025-02-13 French Compare
v14 2025-02-13 English Compare
v13 2025-01-23 French Compare
v12 2025-01-23 English Compare
v11 2025-01-23 French Compare
v10 2025-01-23 English Compare
v9 2025-01-08 French Compare
v8 2025-01-08 English Compare
v7 2024-10-10 French Compare
v6 2024-10-10 English Compare
v5 2024-10-03 French Compare
v4 2024-10-03 English Compare
v3 2024-08-17 English Compare
v2 2024-08-08 French Compare
v1 2024-08-08 English Compare

Showing 1 to 19 of 19